Skip to main content
All Posts By

Beth Newcomb

Study finds potential cardiovascular benefits in rare longevity mutation (Longevity Technology)

By In the News

Longevity Technology featured a study by Valter Longo on how Laron syndrome patients appear to have less risk of heart disease. “These findings suggest that individuals with GHRD have normal or improved levels of cardiovascular disease risk factors compared to their relatives,” said Longo. “Although the population tested is small, together with studies in mice and other organisms this human data provide valuable insights into the health effects of growth hormone receptor deficiency and suggest that drugs or dietary interventions that cause similar effects could reduce disease incidence and possibly extend longevity.”

Imagine living in a 4-foot body that doesn’t develop chronic diseases (CNN)

By In the News

CNN featured a study co-led by Valter Longo that described how patients with Laron syndrome appear to be at reduced risk of heart attack and other illnesses. “We have shown in studies people with Laron have a very low incidence of cancer, diabetes and cognitive decline. Brain scans have shown they have more youthful brains — the equivalent of someone 20 years younger. I have yet to see a case of Alzheimer’s in this population,” Longo said. “It doesn’t mean that they are immune to these diseases, but people with Laron syndrome certainly seem to be very protected. … This is how powerful this mutation seems to be.” The story also appeared on CTV News (Canada).

Close Menu